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Abstract
Rationale: Exogenous stem cell delivery is under investigation to prevent and treat cardiac dysfunction. It is less studied as
to the extent endogenous bone marrow derived stem cells contribute to cardiac homeostais in response to stress and the
affects of aging on this stress response.
Objective: To determine the role of bone marrow (BM) derived stem cells on cardiac homeostasis in response to pressure
overload (PO) and how this response is altered by aging.
Methods and Results: Young (8 weeks) and old (.40 weeks) C57/b6 mice underwent homo- and heterochronic BM
transplantation prior to transverse aortic constriction (TAC). We found that older BM is associated with decreased cardiac
function following TAC. This decreased function is associated with decrease in BM cell engraftment, increased myocyte
apoptosis, decreased myocyte hypertrophy, increased myocardial fibrosis and decreased cardiac function. Additionally,
there is a decrease in activation of resident cells within the heart in response to PO in old mice. Interestingly, these effects
are not due to alterations in vascular density or inflammation in response to PO or differences in ex vivo stem cell migration
between young and old mice.
Conclusions: BM derived stem cells are activated in response to cardiac PO, and the recruitment of BM derived cells are
involved in cardiac myocyte hypertrophy and maintenance of function in response to PO which is lost with aging.
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Introduction
The role of adult stem cells in cardiac repair has been the focus
of intense research, driven by the goal of developing novel
therapies aimed at regenerating damaged myocardium. Several
adult stem cell populations have been shown to enhance cardiac
repair, including bone marrow (BM) and cardiac based stem and
progenitor cell populations, each with potentially different
mechanisms and degrees of effect [1,2,3]. However, most of the
research has focused on their role in acute and chronic myocardial
infarction (MI). A smaller number of studies has focused on the
involvement of bone marrow stem cells (BMSC) in pressure
overload (PO), a clinical condition caused by the increasingly
prevalent diseases of aortic stenosis and hypertension [4,5]. In
response to the increased workload and systolic wall stress, the
myocardium undergoes hypertrophy and to a lesser extent,
hyperplasia, transiently maintaining adequate pump function
[5,6]. However, with time these compensatory mechanisms
become inadequate and heart failure ensues [7]. Excessive
myocardial hypertrophy, reactive fibrosis, and capillary rarefaction
have all been implicated in the transition to failure however their
exact mechanisms remain under study [8,9].
Several groups have identified stem cell involvement in PO in
both human and animal studies [4,6,10]. Urbanek et al. observed
increased numbers of resident cardiac stem cells (CSC) in biopsies
from patients undergoing aortic valve replacement. Mueller et al.
demonstrated increased endothelial progenitor cell recruitment into
the myocardium in mice following transverse aortic constriction
(TAC). The impact of aging in this setting is less well addressed
despite advanced age being frequently associated with the
development of heart failure [4]. Reports have shown the effects of
aging on various stem cell compartments in animals and humans.
Intrinsicstemcellchangeswithagingsuchasincreasedactivityofcell
cycle regulatory pathways can lead to decreased stem cell
populations and decreased stem cell function [11,12,13]. Aging of
the stem cell supportive niche or systemic environment can also have
negativeeffectsas seeninaged skeletalmusclesatellite cellsthatshow
improved function when exposed to younger serum [14].
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15187Here we make the novel observation that the BM is involved in
supporting the myocardium in chronic PO and that this support is
lost with aging. We demonstrate that older BM is associated with
decreased cardiac function in the setting of chronic TAC and that
this decreased function is associated with increased fibrosis,
decreased myocyte hypertrophy, increased apoptosis and de-
creased BM cell engraftment in the myocardium. Interestingly,
these effects of aging are not due to alterations in vascular density
or inflammation in response to PO or differences in ex vivo stem cell
migration between young and old BM. Additionally, we show with
age a decrease in activation of resident cells within the
myocardium in response to PO. Our findings suggest BM stem
cells provide anti-apoptotic, pro-hypertrophic support to myocytes
leading to preservation of cardiac function and mitigating adverse
cardiac remodeling. These effects are attenuated with age possibly
due to a specific BM population of cardioprotective stem cells that
may be the origin of cardiac progenitor cells.
Methods
See Supplemental Material S1 for additional information.
Animals
All animal experiments were approved by the Cleveland Clinic
Institutional Animal Care and Use Committee (ARC-08574).
Male C57BL/6J mice (Jackson Laboratories, 000664) were used in
all experiments unless otherwise noted. Young mice were aged 8
weeks and old mice were aged 40 weeks at the time of operation.
Male C57BL/6J ROSA26 mice expressing beta-galactosidase
(Jackson Laboratories, 002192) were used for bone marrow
transplantations (BMTx). Male C57BL/6J mice with constitutively
active and ubiquitous luciferase expression (Jackson Laboratories,
002709) were used for MSC injections.
Transverse Aortic Constriction
Transverse aortic constriction was performed as previously
described [15]. Briefly, a 7-0 silk suture was constricted around the
transverse aorta against an externally positioned 27 gauge needle
which was removed after tightening. Age-matched sham animals
underwent the same procedure without tightening of the suture. A
total of 91 mice survived surgery and 68 (72%) survived until tissue
collection, 38 of which were old mice. Numbers of animals per
experiment are indicated in their respective legends.
Bone Marrow Transplantation
Bone marrow transplantations using donor ROSA26 mice were
performed as previously described [16]. Irradiated mice received 1
million whole BM cells via femoral injection in both legs. After 5
weeks, mice were assessed for hematologic reconstitution by
complete blood count (Drew Scientific Hemavet) and subjected to
TAC and sham operations as described above.
Echocardiographic Assessment of Heart Function
Transthoracic echocardiography was performed by blinded
observers as previously described [17]. M-mode images were used
to assess cardiac function.
Histological Analysis
Heart tissue was fixed and embedded in paraffin. Five micron
short axis sections from the level of the papillary muscles were cut
and underwent Masson’s trichrome staining for collagen. Whole
sections were imaged at 2006 magnification via bright field
microscopy (Leica DM5000B). Cardiomyocyte diameter was
measured using trans-nuclear width of the shortest diameter of
at least 60 myocytes per section as previously described [18]
Cardiac fibrosis was assessed by measuring the collagen–stained
area as a percentage of total myocardial area as previously
described [17].
Macrophages were quantified as previously described [19,20].
Sections were incubated with a Mac-3 antibody (BD Biosciences).
A peroxidase DAB detection system (Vector Laboratories) was
used per manufacturer’s instructions and sections were counter-
stained with hematoxylin.
For vessel quantification and myocyte density, sections were
incubated with fluorescein-conjugated isolectin (Vector Laborato-
ries), labeling endothelium and rhodamine-conjugated wheat germ
agglutinin (Vector Laboratories), which labels myocyte mem-
branes as previously described [21]. Five randomly chosen cross-
sectional fields for each sample were imaged at 4006 using
confocal microscopy (Leica).
Apoptotic nuclei were determined by terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL) (Roche)
staining per manufacturer’s instructions, and cardiomyocytes were
identified by troponin staining as previously described.
All quantitative evaluations were performed by a blinded
observer using ImagePro Plus software (v61.0.346 Media Cyber-
netics) as previously described [18].
Bone Marrow Migration
Whole BM was isolated as described above and depleted of
lineage positive cells using EasySep Mouse Hematopoietic
Progenitor Enrichment Kit (Stem Cell Technologies) depleting
CD5, CD11b, CD19, CD45R, Ly-6G, TER119, 7/4 positive
cells. 350,000 cells in 0.5% FBS-AMEM in 5 uM pore inserts
(Millipore) were placed in a 6-well plate with 0.5% FBS-AMEM
media with or without either 1.5 ng/mL or 150 ng/mL
recombinant mouse stromal cell-derived factor-1a (SDF-1, R&D
Systems) or 3 ng/mL or 300 ng/mL recombinant mouse
monocyte chemotactic protein-3 (MCP-3, R&D Systems). Cells
were counted with a hemocytometer after migrating for 4 hours at
37uC in hypoxic conditions (5% O2,5 %C O 2).
Flow Cytometric Analysis
Migrated cells were incubated with PE-, or APC- conjugated
monoclonal antibodies against c-Kit and stem cell antigen-1 (SCA-
1) (Becton Dickinson). The appropriate conjugated isotype-
matched IgGs were used as controls. Cells were analyzed using
a LSR II with FACSDiva software (Becton Dickinson).
Chemokine Gene Expression
RNA was isolated using the guanidinium thiocyanate-phenol-
chloroform method (TRIzol, Invitrogen) and reverse transcribed
using random hexemer primers (New England BioLabs). Quan-
titative PCR (qPCR) of cDNA was performed with TaqMan
probes (Applied Biosystems) for the genes of interest SDF-1
(Mm00445552_m1) or MCP-3 (Mm00443113_m1). Expression
was normalized to endogenous 18s expression (Hs99999901_s1).
Data are reported as relative quantification values (RQ) using the
ddCt method as previously described. [22].
Proliferating cell assessment
Twice daily 0.05 mg/g of BrdU (Sigma) was given intraperi-
toneally for three days prior to collecting hearts 2 weeks post-
surgery in young and old non-BMTx mice. Hearts were collected
and prepared for immunostaining as previously mentioned.
Sections were incubated with a fluorescein conjugated monoclonal
antibody to BrdU (Roche), a monoclonal anti-cardiac specific
Bone Marrow Age and Cardiac Repair
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with Alexa Fluor 647 (Molecular Probes) and DAPI (Vector
Laboratories). Incubation with Alexa Fluor 568 goat anti-mouse
IgG antibody (Molecular Probes) for troponin-t secondary labeling
was performed. Eight random fields per animal at 630x were
imaged using confocal microscopy (Leica).
Detection and Quantification of Bone Marrow Cells in the
Heart
Genomic DNA was isolated from left ventricles of BMTx
animals using the guanidinium thiocyanate-phenol-chloroform
method (TRIzol, Invitrogen). qPCR was performed using genomic
DNA and beta-galactosidase primers (for-CCG GAT TGA TGG
TAG TGG TC; rev-AAT CCA TCT TGT TCA ATG GCC
GAT C). Expression was normalized to 18s gene content (Applied
Biosystems, Hs99999901_s1). Data are reported as relative
quantification values (RQ).
Statistics
Values are represented as mean 6 SEM. Paired data were
evaluated using Student’s t test. The between-group differences in
changes of left ventricular echocardiography parameters at 2 and
4 weeks after surgery were evaluated using repeated-measures two-
way analysis of variance. Similarly, histology data obtained at 4
weeks after surgery were compared by a two-way analysis of
variance. Survival curves were determined using Kaplan-Meier
analysis and compared with the log-rank test. All statistical analysis
was done using SPSS 15.0 software (SPSS Inc, Chicago, Il). P
value ,0.05 was considered statistically significant.
Results
Old mice have decreased cardiac function and survival in
response to PO
To investigate the effects of age on cardiac compensation in
response to chronic PO, we measured cardiac function by
echocardiography in young and old mice as a function of time
after TAC or sham procedure. Baseline cardiac function
parameters showed no difference between young and old mice.
However, as expected, left ventricle (LV) mass and body weight
were greater in old mice (Table 1). Ejection fraction (EF) was
significantly lower in old mice (P=0.00019). Expectedly, TAC
reduced EF in young and old mice (P=0.00003, Figure 1B), with
the decrease larger in old mice (P=0.003 for TAC/old age
interaction). Similarly, TAC significantly increased left ventricular
end-systolic dimension (ESD) and was larger in old mice
(P=0.007 and P=0.001, respectively, Figure 1B). Again, the
TAC-mediated increase was more pronounced in old mice
(P=0.018 for TAC/old age interaction). Post-mortem inspection
revealed that old TAC animals had significantly increased heart
weight (HW/BW), left ventricular weight (LVW/BW), and lung
weight (LW/BW) to body weight ratios (Figure 1C) consistent
with decreased function. Furthermore, old TAC mice had
significantly decreased survival 4 weeks following TAC
(P=0.03, Figure 1D). There was no difference in survival rates
in sham animals between age groups.
Inflammation following TAC is similar in young and old
mice
We examined inflammatory cell infiltration of the left
ventricle following TAC between young and old mice as a
possible mechanism for the observed differences in cardiac
function. Several studies have characterized the inflammatory
cell response in pressure overload in young animals [20,23]. Xia
et al. demonstrated no significant neutrophil infiltration
following TAC and a peak infiltration of macrophages within
2 weeks which subsided by 28 days. We compared macrophage
infiltration 2 weeks following TAC which is when differences in
cardiac function between younga n do l dm i c eb e c a m ea p p a r e n t .
Both young and old TAC mice had significantly increased
macrophage infiltration compared to their respective shams
(Figure 1F, 103.665.0 vs. 4.262.7 cells/mm
2, P=0.0003 and
93.261.6 vs.3.863.3 cells/mm
2, P=0.0004, respectively).
However, infiltration between young and old TAC and sham
animals did not differ significantly (P=0.16 and P=0.92,
respectively).
Old BM is associated with decreased cardiac function in
response to PO
To determine a potential role for BMSC in the myocardial
response to PO and whether age attenuates this effect, we
performed a series of BMTx between age groups prior to TAC
(Figure 2A). Five weeks after BMTx, complete blood counts
demonstrated BM reconstitution in all groups (Table S1) and
animals underwent TAC or sham operations and were
monitored for 4 weeks following surgery. We observed no direct
effect of BMTx alone; there were no differences in cardiac
function between animals that received age matched BMTx and
age matched non-transplanted animals before or after TAC
(Figure S1).
At baseline, groups showed no difference in cardiac parameters.
BM age and body age had independent additive effects on the
response of LV function parameters on TAC. Specifically, EF
decreased more in animals with old BM (P=0.002), and in older
animals (P=0.0005, Figure 2B), while ESD and EDD increased
more in animals with old BM (P=0.012 and P=0.002,
respectively), and in older animals (P=0.0006 and P=0.001,
respectively) (Figure 2D and 2F), with no interaction between
animal age and marrow age (P=NS for both interactions). There
were no differences in sham cardiac function between groups
(Figure 2C, 2E, and 2G).
Table 1. Young and old mice cardiac parameters at baseline prior to TAC.
EF (%) FS (%) ESD (mm) EDD (mm) LV Mass (mg) Body Weight (g)
Young 89.360.05 53.660.09 1.360.2 2.960.2 106.4626.9 28.360.1
Old 89.260.07 54.660.11 1.460.2 3.060.2 142.969.4 34.361.0
P-Value 0.99 0.89 0.61 0.99 ,0.01 ,0.001
Cardiac function does not differ between young and old animals prior to surgery. As expected, old animals have greater LV mass and body weight. EF, ejection fraction;
FS, fractional shortening; Mass, left ventricular (LV) mass; ESD, LV end-systolic dimension. n=6 per group.
doi:10.1371/journal.pone.0015187.t001
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remodeling and less compensatory myocyte
hypertrophy in PO
To further characterize the effects of BM age in PO, myocardial
fibrosis and myocyte hypertrophy were measured. All TAC groups
experienced significant increases in fibrosis compared to their
respective shams (Figure 3B). As expected, there were no differences
in sham animals between groups. In TAC mice, the extent of tissue
fibrosis was less in animals with young BM, including old mice with
young BM, compared to animals with old BM, including young
Figure 1. Cardiac function following TAC. (A) Old TAC mice had lower ejection fractions (EF) and (B) greater left ventricular end-systolic
dimension (ESD). (C) Old TAC mice had significantly increased heart weight (HW/BW), left ventricle weight (LVW/BW), and lung weight (LW/BW) to
body weight ratios compared to young TAC mice 4 weeks after TAC. (D) Old TAC mice had decreased survival compared to young TAC mice at 4
weeks post-TAC. *P,0.05 versus young TAC mice. n=6–8 per group. (E) Mac-3 staining (example of positive cells in inset) showed increase in
macrophage infiltration in TAC animals over sham (#P,0.001 compared to shams) but no difference in TAC animals between age groups (P=0.163).
n=3–4 mice per group.
doi:10.1371/journal.pone.0015187.g001
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(Figure 3B). When comparing individual groups, old TAC mice
with young BM had less fibrosis than old mice with old BM
(462.6685.8% vs. 974.96106.1% increase over sham, P,0.01)
(Figure 3C). Fibrosis in young mice with old BM was not
significantly greater than young mice with young BM (Figure 3D).
Similarly, all TAC mice had increased myocyte diameters
compared to their respective shams (Figure 3E). There were no
Figure 2. Decreased cardiac function in pressure overload is associated with older bone marrow (BM). (A) Diagram of bone marrow
transplantation with b-gal donors. (B, D) Old BM and old body age had significant and independent interactions with cardiac function in TAC mice.
There were no differences between YRO and ORY groups. (C, E) There were no differences seen between sham animals. n=7–10 per group. YRY,
young mice with young BM; YRO, old mice with young BM; ORY, young mice with old BM; ORO, old mice with old BM. EF, ejection fraction; EDD,
end-diastolic dimension; ESD, end-systolic dimension.
doi:10.1371/journal.pone.0015187.g002
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young BM had greater myocyte diameters than mice with old BM
(19.560.7 mm vs. 17.260.5 mm, P,0.05) (Figure 3E). When
comparing individual groups old mice with young BM had an
increased hypertrophic response compared to old animals with old
BM (18.562.6% vs. 7.4 vs. 3.2% increase over sham, P,0.05)
(Figure 3F). Young mice with old BM had a reduced hypertrophic
response compared to young mice with young BM (6.062.2% vs.
27.767.1% increase over sham) (Figure 3G).
Increased myocyte death without changes in vascular
density is associated with older BM
Myocyte hypertrophy in response to PO has been shown to
require vascular growth [8,24]. We hypothesized that the benefit
of young BM could be related to the ability to generate an increase
in vascular density and/or minimize vascular rarefaction. To
investigate this relationship we assessed vascular density by
immunofluorescence in cross-sections of the myocardium 4 weeks
following surgery. Although there was evidence of significant
Figure 3. Mice with older bone marrow (BM) have increased cardiac remodeling compared to young BM mice 4-weeks post-TAC.
(A) Masons trichrome staining for collagen. (B) Young BM mice had increased myocyte hypertrophy compared to old BM mice. n=12–14 per group.
(C) Young animals with old BM (ORY) had decreased myocyte hypertrophy compared to young animals with young BM (YRY) n=5–7 per group.
(D) Old mice with young BM (YRO) had increased myocyte hypertrophy compared to old animals with old marrow (ORO). n=5–7 per group. (E) Old
BM mice had increased fibrosis compared to young BM mice. n=12–14 per group. (F) ORY mice did not have significantly greater fibrosis than YRY
mice. n=5–7 per group. (G) YRO mice had reduced fibrosis compared to ORO. n=5–7 per group. #P,0.05 versus respective sham; ##P,0.01
versus respective sham; *P,0.05 versus young BM. Bar represents 200 mM in low magnification and 50 mM in high magnification fields.
doi:10.1371/journal.pone.0015187.g003
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difference in the extent of rarefaction between animals transplant-
ed with young and old BM (Figure 4A).
Since rates of vascular rarefaction in response to TAC is not
affected by age we next examined myocyte dropout. Increased
myocyte apoptosis has been implicated in the transition to heart
failure in PO [25,26]. Increased rates of myocyte loss in animals
with old marrow is suggested by the observed increase in collagen
deposition which could be in part due to replacement fibrosis
following myocyte loss. Therefore we examined myocyte death via
TUNEL staining 4 weeks following surgery. All TAC animals
demonstrated significant increases in TUNEL staining compared
to their respective shams (Figure 4B). Additionally, mice with old
BM, including young mice with old BM, had increased TUNEL
staining compared to animals with young BM, including old mice
with young BM (old vs. young: 0.9160.07% vs. 0.5960.06%
positive nuclei, P,0.01). Comparing individual BMTx groups,
effects of BM and body age were seen. All TAC groups had
greater TUNEL positive nuclei compared to young mice with
young BM (Figure 4D). Both heterochronic groups had similar
TUNEL staining results (0.7360.02% vs. 0.8660.03% positive
nuclei, P=0.388) and were not significantly different than old
animals that received old BM (Figure 4D).
Older age is associated with decreased activation/
proliferation of cells and recruitment of BM cells to the
myocardium following TAC
Increased proliferation of stem cells in the heart in response to
PO has been shown in humans and is associated with cardiac
compensation [6]. To investigate the effects of age on cell
activation and proliferation in the myocardium following TAC, we
quantified cells undergoing DNA synthesis between young and old
mice. Non-BMTx animals were pulsed with BrdU for 3 days prior
to collection 2 weeks post-TAC. This is when differences in
cardiac function between age groups became apparent and when
stem cell involvement could be important for preserving cardiac
function. The number of BrdU positive cells and CSC like, i.e.,
small BrdU positive troponin positive cells (BPTP) [6], which were
identified by quadruple staining, were measured. Consistent with
previous studies, a negligible number (only 3 total) of BrdU
positive myocytes were found. Both TAC groups had more BrdU
positive cells compared to their respective sham controls, however
young TAC mice had more BrdU positive cells than old TAC
mice (245.3630.7 vs 112.2612.4 BrdU cells/mm
2, P,0.05)
(Figure 5B). Importantly, young TAC mice had significantly more
BPTP cells compared to their respective sham controls, repre-
senting a 10-fold increase. This was not the case in old mice.
Furthermore, compared to old TAC, young TAC mice had
significantly more BPTP (15.063.0 vs. 3.161.8 BPTP/mm
2,
P,0.05) (Figure 5C).
To assess the effects of age on BM support of the myocardium
we compared level of BM derived cells in the left ventricle four
weeks following TAC between young BM and old BM animals.
We performed qPCR of genomic DNA for the beta-galactosidase
gene unique to the transplanted BM that was derived from the
ROSA26 mice. Sham animals showed no difference between age
groups, however mice with young BM (young and old animals that
received young BM) demonstrated a 7-fold increase (P,0.05) in
BM derived cells in the left ventricle compared to mice with old
BM (young and old mice that received old BM) (Figure 5D). Old
mice with old marrow demonstrated no increase in BM derived
cells compared to sham (0.8160.40 fold change compared to
sham).
No difference in ex vivo migration capacity between
young and old BM
Based on our observation of decreased stem cell engraftment
into the myocardium of older animals, we wanted to determine if
old BMSC lost their migratory capacity or if older myocardium
lacked the ability to up regulate stem cell homing factors. The
effect of BM transplantation on cardiac function suggests that cells
from the BM migrate to the heart in response to PO. Since aging
affects the expression of genes involved in transmembrane, G-
protein-coupled receptor, and protein tyrosine phosphatase
signaling activity [27], we measured the migration potential of
lineage depleted young and old BM cells in response to MCP-3
and SDF-1; these two chemokines have been shown to be highly
relevant to the recruitment of stem cells to the heart following
injury [28,29]. We compared migration of lineage depleted whole
BM from young and old animals to increasing concentrations of
SDF-1 and MCP-3. Interestingly, there were no differences in the
migratory capacity of primitive cells between young and old BM
(Figure 6A). Additionally, FACS analysis failed to detect significant
changes in the c-Kit and SCA-1 fractions of migrated cells
(Figure 6B). The expression of SDF-1 at 1 and 4 weeks after TAC
was not changed in the LV of young and old mice (Figure 6C)
whereas both groups demonstrated an increase in MCP-3
expression at 1 week post-TAC compared to their respective
sham groups. Interestingly, there was no difference in the
magnitude of increase between age groups (young, 3.361.5 vs.
old, 5.862.1, P=0.58) (Figure 6C). However, at 4 weeks after
TAC, there was increased expression of MCP-3 in young but not
old LV (2.360.3 vs. 0.760.04, P,0.05) (Figure 6D).
Discussion
In this study, we show that old mice have a worse response to
chronic PO, as evidenced by larger end-systolic dimensions, lower
ejection fraction, and finally, lower survival. Furthermore, this
worse response of older animals is not due to differences in
inflammatory cell infiltration but mediated not only by aging of
the heart, but also by aging of the BM. It is important to note that
the older animals in out studies are middle-aged mice and that the
analyses performed could only able be performed on survivors.
Older animals had a greater mortality rate in the first week after
TAC; therefore, they did not survive long enough to allow for
meaningful analyses. Importantly, body age and bone marrow age
appear additive and of similar magnitude, as evidenced by a
similar decline of cardiac function in young animals transplanted
with old BM and old animals transplanted with young BM.
It appears that the effect of young BM is mediated by the
suppression of collagen synthesis, stimulation of myocyte hyper-
trophy, and reduction in myocyte dropout. Consistent with the
findings of decreased myocyte density, we further demonstrate that
aging of the BM leads to a loss of bone marrow-derived cell
engraftment in the myocardium, and a decrease in cardiac
progenitor cell activation/proliferation/migration within the
myocardial tissue in response to PO.
Over the last decade, a variety of BM cells has been utilized for
cardiac repair including hematopoietic stem cells, mesenchymal
stem cells and endothelial progenitor cells [30] as well as more
specific cardiac based stem cell populations [31,32,33]. Compar-
atively fewer studies have defined the role of endogenous BMSC
and aging on trophic support and repair of the heart in response to
stress [10,32]. This report provides several important insights into
the mechanisms of BM support of the myocardium in PO and how
they are affected with age.
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PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15187Figure 4. Myocyte death not vessel density is affected by age. (A) Representative pictomicrographs of vascular density from BMTx mice.
Vessels are identified by isolectin B4 (yellow) immunohistochemistry. WGA was used to mark cell membranes (red); DAPI identifies nuclei (blue). All
TAC groups had significant decreases compared to their respective shams but there was no difference in degree of rarefaction between young and
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remodeling and aids in myocyte survival
Following activation and recruitment of stem cells to the
myocardium, which is attenuated with age, stem cells provide
trophic support through as of yet unknown mechanism. Paracrine
mediators and their effects have been studied extensively in the
setting of MI where stem cells can have a significant impact on
scar remodeling and myocyte survival [34,35]. In our hetero-
chronic BMTx model, increased myocyte hypertrophy and
decreased fibrosis is associated with young BM.
In addition to hypertrophy and decreased fibrosis, young
BMSC are associated with myocyte survival, similar to responses
seen in MI. In our model, myocyte death is influenced by age.
Young mice with young marrow had decreased myocyte death at
4 weeks compared to old animals with old marrow. Young mice
also did not demonstrate a decrease in density whereas animals
with old BM did. The increased fibrosis seen with aged BM is
likely due in part to reactive scarring in response to myocyte
dropout. Old animals demonstrated significantly worse survival
compared to young mice and analysis were performed only on
Figure 5. Young animals had increased proliferating cells, cardiac stem cell (CSC) like cells, and bone marrow (BM) derived cells
compared to old animals following TAC. (A) Representative staining of proliferating cells and CSC like, small BrdU positive troponin positive
(BPTP) cells in young and old non-bone marrow transplanted animals. Quadruple staining (BrdU, green; DAPI, blue; WGA, purple; troponin, red) was
performed. (B) Young mice had more proliferating cells in their myocardium compared to old animals 2 weeks post-TAC. (C) Young mice had more
CSC like cells compared to old animals 2 weeks post-TAC. (D) Mice with young BM (YRY, YRO) had more cumulative BM derived cells 4-weeks post-
TAC than mice with old BM (ORO, ORY) as measured by PCR for genomic DNA unique to transplanted marrow.
#P,0.05 versus respective sham;
*P,0.05 versus old mice; n=5 per group. Bar in upper panel represents 50 mM and 5 mM in lower panel.
doi:10.1371/journal.pone.0015187.g005
old mice. (B) Representative pictomicrograph of TUNEL positive myocyte. Triple staining (TUNEL, green; DAPI, blue; troponin, red) was performed 4
weeks after TAC. (C) Both young and old bone marrow (BM) TAC animals show significantly increased apoptosis compared to their respective sham
(*, P,0.001), however old BM mice (ORO, ORY) have increased apoptosis compared to young BM mice (YRY, YRO) (
#P=0.03) n=7–9 per group.
(D) Old BM and old body age are associated with increased TUNEL positive nuclei in TAC mice. n=5–7 per group. YRY, young mice with young BM;
YRO, old mice with young BM; ORY, young mice with old BM; ORO, old mice with old BM. Bar represents 50 mM.
doi:10.1371/journal.pone.0015187.g004
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PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e15187Figure 6. No difference in ex vivo migration potential between young and old bone marrow (BM) progenitor cells. (A) There was no
difference in migration between non-manipulated young and old BM progenitor cells exposed to low and high concentrations of SDF-1 and MCP-3.
(B) Both young and old non-bone marrow transplanted TAC animals had increased cardiac MCP-3 expression 1-week after TAC, however old TAC
mice expression returned to baseline by 4-weeks whereas young TAC mice expression levels remained elevated. (C) There was no difference in SDF-1
expression at 1- or 4-weeks post-TAC between age groups. (D) FACS analysis of c-Kit and SCA-1 positive populations of migrated young and old
BMSC showed no difference in bone marrow stem cell population composition. *P,0.05 versus old animals. n=5 per group.
doi:10.1371/journal.pone.0015187.g006
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could be more pronounced.
Surprisingly, there was no difference in degree of vessel
rarefaction following TAC between young and old BM suggesting
that the benefit associated with young BM in PO is not due to the
improved release of endothelial progenitor cells as has been seen in
other disease models involving stem cell aging [36]. This does not
exclude a role for the BM in angiogenesis in PO which has
previously been indicated [37]; however, it appears that this
response to TAC may be minimally affected by age.
Decreased proliferation, activation, and recruitment of
stem cells to the heart in response to TAC with age
Both young and old TAC animals had increased proliferating
small non-myocyte cells which are most likely a combination of
BM and cardiac based stem cells. However, older TAC mice had
significantly less. More importantly, older TAC animals did not
have an increase in the number of small BrdU positive CSC like
cells whereas young TAC animals experienced a 10-fold increase
over sham. These data are corroborated by the observation of
decreased myocardial recruitment of BM cells after 4 weeks of
banding in old BM animals.
Interestingly, ex vivo measurements of migration potential
showed no difference between young and old BMSC or a
difference in stem cell composition of migrated populations,
suggesting that at baseline old BM migratory response is
comparable to young BM. However, in the chronic state of PO,
these effector stem cell populations are exhausted by the second
week as suggested by the decline in cardiac function, BrdU
proliferation and bone marrow engraftment data.
While the focus of our findings is on the role of BM age on the
myocardial response to PO, our study also demonstrates the
importance of heart age, which is supported by a large body of
important work [38,39,40]. Young BM did not completely rescue
older TAC animals nor did young TAC animals have as poor of
function when given old BM. This could be due to various reasons
including altered myocyte responses at the molecular level that are
heavily engaged during PO [38,41]. Decreased myocardial stem
cell chemokine expression with age could also contribute to poor
function. Older TAC hearts had baseline levels of MCP-3
expression at 4 weeks, which was significantly less than young
TAC heart expression. However, young BM was still able to
respond to older TAC hearts. It is also possible that CSC
populations are affected by age. In our study, old TAC animals
had a decrease in BrdU positive and in CSC like BrdU positive
troponin positive cells.
Other researchers have shown that the BM acts as a progenitor
cell reserve for other non-hematological adult progenitor cell
populations [42]. Thus, in a stressed state, CSC are actively
involved in repair and their reserves are replaced by BM derived
cells. Our findings support this concept of BM replenishment of
CSC occurs in PO.
Our data have important implications for understanding the
role of the BM in the homeostasis of cardiac function in the setting
of PO. We demonstrated that BM derived cells can support the
myocardium on a relatively acute basis (,1 month) independent of
myocardial regeneration and that this ability is lost with age
possibly due to a loss of a specific BM stem cell population. Further
defining this population and understanding the role of age in its
decline could facilitate our understanding of the role of the bone
marrow in maintaining myocardial homeostasis in heart disease as
well as the development of novel stem cell targeted adjunct
therapies for patients undergoing aortic valve replacement and
who have poor cardiac function.
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